SHMT2 and breast carcinoma: Bernhardt et al. [29] analyzed breast cancer specimens from 801 consecutive patients and identified SHMT2 and ASCT2 protein expression as novel potential prognostic biomarkers for breast cancer, as their high protein expression was associated with poor outcome.